- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The MorphoSys AG The Evolution of a Biotechnology Business Model VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The MorphoSys AG The Evolution of a Biotechnology Business Model VRIO Analysis shows that the financial resources of MorphoSys AG The Evolution of a Biotechnology Business Model are highly valuable as these help in investing into external opportunities that arise. These also help MorphoSys AG The Evolution of a Biotechnology Business Model in combating external threats.
- According to the VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The MorphoSys AG The Evolution of a Biotechnology Business Model VRIO Analysis shows that MorphoSys AG The Evolution of a Biotechnology Business Model's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of MorphoSys AG The Evolution of a Biotechnology Business Model's products.
- According to the VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for MorphoSys AG The Evolution of a Biotechnology Business Model. These patents also provide MorphoSys AG The Evolution of a Biotechnology Business Model with licensing revenue when it licenses these patents out to other manufacturers.
- The MorphoSys AG The Evolution of a Biotechnology Business Model VRIO Analysis shows that MorphoSys AG The Evolution of a Biotechnology Business Model’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for MorphoSys AG The Evolution of a Biotechnology Business Model. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The MorphoSys AG The Evolution of a Biotechnology Business Model VRIO Analysis shows that the research and development at MorphoSys AG The Evolution of a Biotechnology Business Model is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for MorphoSys AG The Evolution of a Biotechnology Business Model. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of MorphoSys AG The Evolution of a Biotechnology Business Model are found to be rare according to the VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by MorphoSys AG The Evolution of a Biotechnology Business Model VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as MorphoSys AG The Evolution of a Biotechnology Business Model and inhibit competitive advantage. This means that the local food products result in competitive parity for MorphoSys AG The Evolution of a Biotechnology Business Model. As this resource is valuable, MorphoSys AG The Evolution of a Biotechnology Business Model can still make use of this resource.
- The employees of MorphoSys AG The Evolution of a Biotechnology Business Model are a rare resource as identified by the VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of MorphoSys AG The Evolution of a Biotechnology Business Model are a rare resource as identified by the MorphoSys AG The Evolution of a Biotechnology Business Model VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows MorphoSys AG The Evolution of a Biotechnology Business Model to use them without interference from the competition.
- The distribution network of MorphoSys AG The Evolution of a Biotechnology Business Model is a rare resource as identified by the VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of MorphoSys AG The Evolution of a Biotechnology Business Model. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of MorphoSys AG The Evolution of a Biotechnology Business Model are costly to imitate as identified by the MorphoSys AG The Evolution of a Biotechnology Business Model VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by MorphoSys AG The Evolution of a Biotechnology Business Model provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of MorphoSys AG The Evolution of a Biotechnology Business Model are also not costly to imitate as identified by the MorphoSys AG The Evolution of a Biotechnology Business Model VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from MorphoSys AG The Evolution of a Biotechnology Business Model by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of MorphoSys AG The Evolution of a Biotechnology Business Model a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of MorphoSys AG The Evolution of a Biotechnology Business Model are very difficult to imitate as identified by the VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of MorphoSys AG The Evolution of a Biotechnology Business Model is also very costly to imitate by competition as identified by the MorphoSys AG The Evolution of a Biotechnology Business Model VRIO Analysis. This has been developed over the years gradually by MorphoSys AG The Evolution of a Biotechnology Business Model. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of MorphoSys AG The Evolution of a Biotechnology Business Model are organised to capture value as identified by the VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for MorphoSys AG The Evolution of a Biotechnology Business Model.
- The Patents of MorphoSys AG The Evolution of a Biotechnology Business Model are not well organised as identified by the MorphoSys AG The Evolution of a Biotechnology Business Model VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if MorphoSys AG The Evolution of a Biotechnology Business Model starts selling patented products before the patents expire.
- The distribution network of MorphoSys AG The Evolution of a Biotechnology Business Model is organised as identified by the VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model. MorphoSys AG The Evolution of a Biotechnology Business Model uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for MorphoSys AG The Evolution of a Biotechnology Business Model.
From the VRIO Analysis of MorphoSys AG The Evolution of a Biotechnology Business Model, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of MorphoSys AG The Evolution of a Biotechnology Business Model is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Dominik Micheal
5.0
The project was delivered by this company that I could afford. Now I’ll use this service whenever I need it.
Wei Peng
5.0
This service is the better option for the students of Management! Hire it and make the life stress-free.
Rachel Mitch
5.0
This service met all specifications expected and I'm going to hand over my dissertation to it. Thanks a lot!
Alesia Salvatore
5.0
When I found this service, I decided to give it a try. The customer support was very professional and guided me about every step. I had communication with the writer and he was very cooperative. The assignment was fine. Thanks a lot!
Next Articles
- Microsoft Server & Tools (C) Vrio Analysis
- Life Sciences Revolution: A Technical Primer Vrio Analysis
- Jewellworld.com: Leading Web Based IT Development In The Jewellery Industry Vrio Analysis
- Baria Planning Solutions, Inc.: Fixing The Sales Process, Spanish Version Vrio Analysis
- WeServeHomes.com Vrio Analysis
- IntellectExchange, Inc. Vrio Analysis
- Frameworks For General Management And Operations Consulting Vrio Analysis
- Services Supply Management: The Next Frontier For Improved Organizational Performance Vrio Analysis
- CIGNA Property And Casualty Reengineering (A) Vrio Analysis
- Auctionwire's Vicious Circle Vrio Analysis
Previous Articles
- Tata Consultancy Services: Sustaining Growth Momentum In China 2010 Vrio Analysis
- Alexander Bandelli (B) Vrio Analysis
- Microsoft Server & Tools (B) Vrio Analysis
- International Profit Associates Vrio Analysis
- General Dynamics And Computer Sciences Corporation: Outsourcing The IS Function (C) Vrio Analysis
- Fsas: Fujitsu Support And Service, Inc. Vrio Analysis
- Influencing Customer Behavior In Service Operations Vrio Analysis
- Genzyme And The Research Ethics Questions Associated With Its NeuroCell PD (TM) Trials Vrio Analysis
- In Vivo To In Vitro To In Silico: Coping With Tidal Waves Of Data At Biogen Vrio Analysis
- E Consulting, Spanish Version Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!